
Marco Siccardi
Liverpool, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 111 publications
Physiologically based pharmacokinetic modeling of drug-drug interactions between ritonavir-boosted atazanavir and rifampicin in pregnancy.
Journal: CPT: pharmacometrics & systems pharmacology
Published: July 17, 2024
DeepARV: ensemble deep learning to predict drug-drug interaction of clinical relevance with antiretroviral therapy.
Journal: NPJ systems biology and applications
Published: August 18, 2023
Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 27, 2023
Physiologically-based pharmacokinetic modelling of long-acting injectable cabotegravir and rilpivirine in pregnancy.
Journal: British journal of clinical pharmacology
Published: May 31, 2023
General Framework to Quantitatively Predict Pharmacokinetic Induction Drug-Drug Interactions Using In Vitro Data.
Journal: Clinical pharmacokinetics
Published: February 21, 2023
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling.
Journal: European journal of drug metabolism and pharmacokinetics
Published: December 14, 2022
The LEAP Process: Streamlining the Development of Long-Acting Products and Formulations for Infectious Diseases.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 21, 2022
Evaluation of drug-drug interaction between rilpivirine and rifapentine using PBPK modelling.
Journal: Frontiers in pharmacology
Published: October 21, 2022
Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study.
Journal: Contraception
Published: September 22, 2022
Correction to: Predicting Drug-Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling.
Journal: Clinical pharmacokinetics
Published: September 16, 2022
Last Updated: 09/26/2026